Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
74.78
+4.62 (6.58%)
At close: Jun 26, 2026, 4:00 PM EDT
78.44
+3.66 (4.89%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Disc Medicine Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Disc Medicine stock have an average target of 106.56, with a low estimate of 79 and a high estimate of 154. The average target predicts an increase of 42.50% from the current stock price of 74.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Disc Medicine stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 16, 2026 |
| Wedbush | Wedbush | Buy Maintains $88 | Buy | Maintains | $88 | +17.68% | Jun 16, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $80 → $85 | Buy | Reiterates | $80 → $85 | +13.67% | Jun 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $100 | Buy | Maintains | $100 | +33.73% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 8, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
32.24M
EPS This Year
-7.16
from -6.01
EPS Next Year
-7.59
from -7.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 81.0M | |
| Avg | n/a | 32.2M | |
| Low | n/a | 6.2M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 542.1% |
| Avg | - | 326.6% |
| Low | - | 61.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.55 | -5.93 | |
| Avg | -7.16 | -7.59 | |
| Low | -8.03 | -8.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.